oxprenolol has been researched along with hydralazine in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 30 (83.33) | 18.7374 |
1990's | 1 (2.78) | 18.2507 |
2000's | 3 (8.33) | 29.6817 |
2010's | 2 (5.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Howson, W; Reavill, DR; Slater, RA; Swayne, GT; Taylor, EM | 1 |
Topliss, JG; Yoshida, F | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Boulogne, M; Honore, P; Lanciaux, B; Monnier, JC | 1 |
Fusco, M; Lombardo, M; Valente, D | 1 |
Corvol, P; Gouin, F; Menard, J; Milliez, P; Plouin, PF | 1 |
Hua, AS; Kalowski, S; Kincaid-Smith, P; Whitworth, JA | 1 |
Backer, P; Gyntelberg, F; Jacobsen, K; Martlev, A | 1 |
Hansen, M; Hansen, OP; Lindholm, J | 1 |
Davies, IB; Rosenthal, T; Sever, PS | 1 |
Franz, IW; Lohmann, FW | 1 |
Forrest, WA | 1 |
Kennedy, AC; McKillop, JH; Ward, DM; Winchester, JF | 1 |
Koch, G | 1 |
Freeman, JW; Knight, LW | 1 |
Goble, AJ | 1 |
Jounela, AJ; Mattila, MJ; Pasanen, M | 1 |
Berchel, C; Breart, G; Dalle, M; Goujon, H; Keller, ME; Llado, J; Plouin, PF | 1 |
Gallery, ED; Gyory, AZ; Ross, MR | 1 |
Freis, ED; Kyle, MC | 1 |
Jänne, J; Keyriläinen, O; Koskinen, P; Leskinen, O; Pitkäjärvi, T; Reinikainen, M; Siitonen, L | 1 |
Hodler, J; Messerli, F; Tuckman, J | 1 |
Hodler, J; Martin, R; Tuckman, J | 1 |
Sandström, B | 1 |
Freis, ED | 1 |
Krönig, B; Wendt, G | 1 |
Brechbühler, S; Degen, PH; Dieterle, W; Dörhöfer, G; Feldmann, KF; Riess, W | 1 |
Hilgert, A; Horch, G | 1 |
Siitonen, L | 1 |
Gerc, V; Numić, N | 1 |
Fadul Neto, J; Moscovici, H; Yasbeck Júnior, P | 1 |
Kelly, J; O'Boyle, CP; O'Brien, ET; O'Malley, K | 1 |
García Sacristán, A | 1 |
1 review(s) available for oxprenolol and hydralazine
Article | Year |
---|---|
Estimation of the individual metabolic state and its consideration in optimal pharmacotherapy.
Topics: Biotransformation; Carbamazepine; Diclofenac; Humans; Hydralazine; Kinetics; Maprotiline; Metabolism; Oxprenolol; Pharmaceutical Preparations | 1983 |
16 trial(s) available for oxprenolol and hydralazine
Article | Year |
---|---|
[An example of an acceptable combination in the treatment of arterial hypertension].
Topics: Adult; Aged; Clinical Trials as Topic; Dihydralazine; Double-Blind Method; Drug Combinations; Drug Evaluation; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Oxprenolol; Placebos | 1978 |
Hydrallazine with beta-blocker and diuretic in the treatment of hypertension. A double-blind crossover study.
Topics: Adult; Aged; Cyclopenthiazide; Double-Blind Method; Drug Therapy, Combination; Humans; Hydralazine; Hypertension; Male; Middle Aged; Oxprenolol | 1979 |
[2 antihypertensive therapeutic regimes compared in a controlled clinical trial in general practice. Cyclopenthiazide + KC1/methyldopa versus oxprenolol/hydralazine].
Topics: Adult; Clinical Trials as Topic; Cyclopenthiazide; Diuretics; Drug Evaluation; Drug Therapy, Combination; Economics, Medical; Humans; Hydralazine; Hypertension; Methyldopa; Middle Aged; Oxprenolol; Potassium Chloride; Sodium Chloride Symporter Inhibitors; Time Factors | 1977 |
Controlled clinical study on antihypertensive treatment with a diuretic and methyldopa compared with a beta-blocking agent and hydralazine.
Topics: Blood Pressure; Clinical Trials as Topic; Cyclopenthiazide; Diuretics; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydralazine; Hypertension; Male; Methyldopa; Middle Aged; Oxprenolol; Physical Exertion; Sodium Chloride Symporter Inhibitors | 1977 |
Sympathetic reflex responses during treatment of essential hypertension with hydrallazine and oxprenolol.
Topics: Blood Pressure; Humans; Hydralazine; Hypertension; Norepinephrine; Oxprenolol; Posture; Reflex; Renin; Sympathetic Nervous System | 1979 |
Hydrallazine or phentolamine as adjuncts to beta-adrenoceptor blockade/thiazide therapy in hypertension.
Topics: Adult; Benzothiadiazines; Clinical Trials as Topic; Diuretics; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Oxprenolol; Phentolamine; Placebos; Sodium Chloride Symporter Inhibitors | 1976 |
A randomized comparison of early with conservative use of antihypertensive drugs in the management of pregnancy-induced hypertension.
Topics: Adult; Birth Weight; Cesarean Section; Dihydralazine; Double-Blind Method; Drug Therapy, Combination; Female; Fetal Death; Gestational Age; Humans; Hydralazine; Hypertension; Infant, Newborn; Labor, Obstetric; Length of Stay; Oxprenolol; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Randomized Controlled Trials as Topic | 1990 |
Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa.
Topics: Adult; Birth Weight; Clinical Trials as Topic; Female; Humans; Hydralazine; Hypertension; Infant, Newborn; Male; Methyldopa; Oxprenolol; Pregnancy; Pregnancy Complications, Cardiovascular; Random Allocation | 1985 |
Hydralazine and beta-adrenergic blockade in the treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Oxprenolol; Placebos | 1974 |
Treatment of hypertension with large doses of the beta-adrenergic blocking drug oxprenolol, alone, and in combination with the vasodilator dihydralazine.
Topics: Chlorothiazide; Clinical Trials as Topic; Drug Synergism; Furosemide; Heart Rate; Hydralazine; Hypertension; Hypertension, Malignant; In Vitro Techniques; Oxprenolol; Posture; Vasodilator Agents | 1973 |
Veterans Administration cooperative study on nadolol as monotherapy and in combination with a diuretic.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Bendroflumethiazide; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Therapy, Combination; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nadolol; Oxprenolol; Propanolamines; Propranolol; Random Allocation; Renin; United States; United States Department of Veterans Affairs | 1984 |
[Treatment of refractory hypertension with a fixed oxprenolol/chlorthalidone/hydralazine combination. Results of an open multicenter trial].
Topics: Chlorthalidone; Clinical Trials as Topic; Drug Combinations; Female; Humans; Hydralazine; Hypertension; Isoindoles; Male; Middle Aged; Oxprenolol | 1983 |
[Long-term experiences with an antihypertensive combination].
Topics: Chlorthalidone; Clinical Trials as Topic; Drug Combinations; Female; Humans; Hydralazine; Hypertension; Male; Oxprenolol | 1982 |
Hydralazine and oxprenolol in the treatment of hypertension and the effect of these drugs on plasma renin activity.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydralazine; Hypertension; Male; Middle Aged; Oxprenolol; Placebos; Renin | 1980 |
[Use of oxprenolol, triamterene, and dihydralazine in the treatment of essential hypertension].
Topics: Adult; Aged; Clinical Trials as Topic; Dihydralazine; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Oxprenolol; Triamterene | 1980 |
Once daily slow-release hydralazine in hypertension.
Topics: Adult; Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Oxprenolol | 1981 |
19 other study(ies) available for oxprenolol and hydralazine
Article | Year |
---|---|
Design and synthesis of a series of combined vasodilator/beta-adrenoceptor antagonists based on 6-arylpyridazinones.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Cats; Female; Male; Pyridazines; Rats; Structure-Activity Relationship; Sympathomimetics; Vasodilator Agents | 1988 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
[Value of hydralazine-beta blockader association in hypertension of pregnancy].
Topics: Adrenergic beta-Antagonists; Adult; Drug Therapy, Combination; Female; Fetus; Humans; Hydralazine; Hypertension; Oxprenolol; Pindolol; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Propranolol | 1978 |
[The role of renin after betablocking diuretic and vasodilator treatment in essential hypertension (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Chlorthalidone; Diuretics; Drug Therapy, Combination; Female; Heart Septal Defects, Ventricular; Humans; Hydralazine; Male; Middle Aged; Oxprenolol; Renin; Vasodilator Agents | 1979 |
[Ergometry in the assessment of antihypertensive treatment (author's transl)].
Topics: Adult; Aged; Antihypertensive Agents; Chlorthalidone; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Oxprenolol; Physical Exertion | 1978 |
Efficacy of a combination of diuretic, beta-blocker and vasodilator in the treatment of hypertension in general practice.
Topics: Adult; Aged; Cyclopenthiazide; Delayed-Action Preparations; Diuretics; Drug Therapy, Combination; Family Practice; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Oxprenolol; Sodium Chloride Symporter Inhibitors | 1978 |
Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combination of beta-receptor blocking and vasodilator agent.
Topics: Adult; Blood Pressure; Cardiac Output; Female; Heart Rate; Hemodynamics; Humans; Hydralazine; Hypertension; Lactates; Male; Middle Aged; Oxprenolol; Oxygen; Physical Exertion; Posture; Vascular Resistance | 1976 |
Oxprenolol and hydrallazine in the treatment of hypertension.
Topics: Adult; Diuretics; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Methyldopa; Middle Aged; Oxprenolol | 1975 |
Diuretics, beta blockers and vasodilators. Dosage in mild and moderate hypertension.
Topics: Cyclopenthiazide; Diuretics; Drug Therapy, Combination; Humans; Hydralazine; Hypertension; Male; Middle Aged; Oxprenolol; Sodium Chloride Symporter Inhibitors | 1975 |
Acetylator phenotype and the antihypertensive response to hydralazine.
Topics: Acetylation; Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydralazine; Hypertension; Male; Middle Aged; Oxprenolol; Phenotype; Polymorphism, Genetic; Sulfamethazine | 1975 |
Serial measurements of systolic time intervals during treatment with hydrochlorothiazide alone and combined with other antihypertensive agents.
Topics: Antihypertensive Agents; Drug Therapy, Combination; Electrocardiography; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Myocardial Contraction; Oxprenolol; Prazosin; Propranolol; Systole; Time Factors | 1985 |
[Treatment of hypertension with high doses of oxprenolol alone or in combination with the vasodilator dihydralazine].
Topics: Amino Alcohols; Cardiac Output; Diuretics; Drug Synergism; Humans; Hydralazine; Hypertension; Oxprenolol; Pulse; Sympatholytics | 1972 |
Clinical trials of adrenergic antagonists in pregnancy hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Apgar Score; Birth Weight; Female; Fetal Growth Retardation; Humans; Hydralazine; Hypertension; Infant, Newborn; Methyldopa; Metoprolol; Oxprenolol; Pregnancy; Pregnancy Complications, Cardiovascular; Respiratory Distress Syndrome, Newborn | 1984 |
[Slow-release hydralazine in the treatment of essential arterial hypertension].
Topics: Adult; Blood Pressure; Delayed-Action Preparations; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Oxprenolol; Propranolol | 1982 |
[Combined action of oxprenolol, hydrochlorothiazide and hydralazine in rats with metacorticoid induced hypertension].
Topics: Animals; Desoxycorticosterone; Drug Evaluation; Drug Therapy, Combination; Hydralazine; Hydrochlorothiazide; Hypertension; Oxprenolol; Rats | 1980 |